← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 2.0% below its 1-year high (as of 2026-09-17). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 8.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
NBH
NEUBERGER MUNICIPAL FUND INC.
Valuation N/A
Unknown
Price$9.75
Model IV—
P/IV—
Limited data — see page
NBIS
Nebius Group N.V.
Valuation N/A
Technology Risk 50 · Elevated
Price$207.37
Model IV—
P/IV—
Market implies +109.7%/yr vs model +2.0% · above model
NBP
NovaBridge Biosciences
Valuation N/A
Healthcare Risk 29 · Moderate
Price$1.59
Model IV—
P/IV—
Market implies +88.8%/yr vs model +15.0% · above model
NBRG
Newbridge Acquisition Ltd
Valuation N/A
Financial Services Risk 32 · Moderate
Price$10.09
Model IV—
P/IV—
Limited data — see page
NBRGR
Newbridge Acquisition Ltd
Valuation N/A
Financial Services Risk 32 · Moderate
Price$0.23
Model IV—
P/IV—
Limited data — see page
NBRGU
Newbridge Acquisition Ltd
Valuation N/A
Financial Services Risk 38 · Moderate
Price$10.23
Model IV—
P/IV—
Limited data — see page
NBTX
Nanobiotix S.A.
Valuation N/A
Healthcare Risk 46 · Elevated
Price$35.73
Model IV—
P/IV—
Limited data — see page
NBXG
Neuberger Next Generation Connectivity Fund Inc.
Valuation N/A
Unknown
Price$15.42
Model IV—
P/IV—
Limited data — see page
NCA
NUVEEN CALIFORNIA MUNICIPAL VALUE FUND
Valuation N/A
Unknown
Price$8.88
Model IV—
P/IV—
Limited data — see page
NCEL
NewcelX Ltd.
Valuation N/A
Healthcare Risk 30 · Moderate
Price$3.30
Model IV—
P/IV—
Limited data — see page
NCIQ
Hashdex Nasdaq CME Crypto Index ETF
Valuation N/A
Financial Services Risk 58 · Elevated
Price$20.06
Model IV—
P/IV—
Limited data — see page
NCNA
NuCana plc
Valuation N/A
Healthcare Risk 59 · Elevated
Price$1.32
Model IV—
P/IV—
Limited data — see page
NCPL
Netcapital Inc.
Valuation N/A
Financial Services Risk 33 · Moderate
Price$0.45
Model IV—
P/IV—
Market implies +40.2%/yr vs model +2.0% · above model
NCTY
The9 LTD
Valuation N/A
Financial Services Risk 40 · Elevated
Price$4.18
Model IV—
P/IV—
Market implies +117.7%/yr vs model +2.0% · above model
NCV
Virtus Convertible & Income Fund
Valuation N/A
Unknown
Price$16.17
Model IV—
P/IV—
Limited data — see page
NCZ
Virtus Convertible & Income Fund II
Valuation N/A
Unknown
Price$15.26
Model IV—
P/IV—
Limited data — see page
NDMO
Nuveen Dynamic Municipal Opportunities Fund
Valuation N/A
Unknown
Price$9.35
Model IV—
P/IV—
Limited data — see page
NDRA
ENDRA Life Sciences Inc.
Valuation N/A
Healthcare Risk 43 · Elevated
Price$5.62
Model IV—
P/IV—
Limited data — see page
NEA
Nuveen AMT-Free Quality Municipal Income Fund
Valuation N/A
Unknown
Price$10.85
Model IV—
P/IV—
Limited data — see page
NEGG
Newegg Commerce, Inc.
Valuation N/A
Consumer Cyclical Risk 44 · Elevated
Price$14.67
Model IV—
P/IV—
Limited data — see page
NEN
NEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP
Valuation N/A
Real Estate
Price$54.64
Model IV—
P/IV—
Limited data — see page
NEON
Neonode Inc.
Valuation N/A
Technology Risk 33 · Moderate
Price$0.83
Model IV—
P/IV—
Market implies +26.8%/yr vs model +2.0% · above model
NEOV
NeoVolta Inc.
Valuation N/A
Technology Risk 31 · Moderate
Price$3.67
Model IV—
P/IV—
Market implies +43.0%/yr vs model +15.0% · above model
NEOVW
NeoVolta Inc.
Valuation N/A
Technology Risk 37 · Moderate
Price$1.33
Model IV—
P/IV—
Market implies +40.6%/yr vs model +2.0% · above model
NERV
Minerva Neurosciences, Inc.
Valuation N/A
Healthcare Risk 44 · Elevated
Price$3.83
Model IV—
P/IV—
Limited data — see page
NET
Cloudflare, Inc.
Valuation N/A
Technology Risk 32 · Moderate
Price$314.18
Model IV—
P/IV—
Market implies +34.9%/yr vs model +34.8% · in line
NEWP
NEW PACIFIC METALS CORP
Valuation N/A
Basic Materials Risk 37 · Moderate
Price$5.70
Model IV—
P/IV—
Limited data — see page
NEXA
Nexa Resources S.A.
Valuation N/A
Basic Materials Risk 31 · Moderate
Price$13.31
Model IV—
P/IV—
Limited data — see page
NEXM
NexMetals Mining Corp.
Valuation N/A
Basic Materials Risk 51 · Elevated
Price$2.31
Model IV—
P/IV—
Limited data — see page
NEXN
Nexxen International Ltd.
Valuation N/A
Technology Risk 43 · Elevated
Price$9.36
Model IV—
P/IV—
Limited data — see page
NFGC
New Found Gold Corp.
Valuation N/A
Basic Materials Risk 33 · Moderate
Price$1.69
Model IV—
P/IV—
Limited data — see page
NFJ
Virtus Dividend, Interest & Premium Strategy Fund
Valuation N/A
Financial Services
Price$15.70
Model IV—
P/IV—
Limited data — see page
NG
NOVAGOLD RESOURCES INC
Valuation N/A
Basic Materials Risk 39 · Moderate
Price$8.07
Model IV—
P/IV—
Market implies +74.6%/yr vs model +5.0% · above model
NGEN
NERVGEN PHARMA CORP.
Valuation N/A
Healthcare Risk 54 · Elevated
Price$2.20
Model IV—
P/IV—
Limited data — see page
NGNE
Neurogene Inc.
Valuation N/A
Healthcare Risk 46 · Elevated
Price$37.61
Model IV—
P/IV—
Market implies +106.3%/yr vs model +15.0% · above model
NHIC
NewHold Investment Corp. III
Valuation N/A
Financial Services
Price$10.62
Model IV—
P/IV—
Limited data — see page
NHICU
NewHold Investment Corp. III
Valuation N/A
Financial Services
Price$11.47
Model IV—
P/IV—
Limited data — see page
NHICW
NewHold Investment Corp. III
Valuation N/A
Financial Services
Price$1.30
Model IV—
P/IV—
Limited data — see page
NHIVU
NewHold Investment Corp IV
Valuation N/A
Financial Services
Price$10.32
Model IV—
P/IV—
Limited data — see page
NHS
Neuberger High Yield Strategies Fund Inc.
Valuation N/A
Unknown
Price$5.85
Model IV—
P/IV—
Limited data — see page
NICM
NICOLA MINING INC.
Valuation N/A
Basic Materials
Price$6.14
Model IV—
P/IV—
Limited data — see page
NIE
Virtus Equity & Convertible Income Fund
Valuation N/A
Unknown
Price$25.01
Model IV—
P/IV—
Limited data — see page
NIM
NUVEEN SELECT MATURITIES MUNICIPAL FUND
Valuation N/A
Unknown
Price$9.02
Model IV—
P/IV—
Limited data — see page
NINE
Nine Energy Service, Inc.
Valuation N/A
Energy Risk 74 · High
Price$10.24
Model IV—
P/IV—
Market implies +28.0%/yr vs model +8.0% · above model
NIO
NIO Inc.
Valuation N/A
Consumer Cyclical Risk 34 · Moderate
Price$3.67
Model IV—
P/IV—
Market implies +53.0%/yr vs model +8.0% · above model
NIOBW
NIOCORP DEVELOPMENTS LTD
Valuation N/A
Basic Materials Risk 46 · Elevated
Price$1.08
Model IV—
P/IV—
Market implies +43.8%/yr vs model +5.0% · above model
NIU
Niu Technologies
Valuation N/A
Consumer Cyclical Risk 44 · Elevated
Price$2.07
Model IV—
P/IV—
Market implies +28.3%/yr vs model +3.4% · above model
NIXX
Nixxy, Inc.
Valuation N/A
Technology Risk 30 · Moderate
Price$0.54
Model IV—
P/IV—
Market implies -50.0%/yr vs model +44.9% · below model
NIXXW
Nixxy, Inc.
Valuation N/A
Technology Risk 43 · Elevated
Price$0.00
Model IV—
P/IV—
Market implies +15.0%/yr vs model +2.0% · above model
NKLR
Terra Innovatum Global N.V.
Valuation N/A
Industrials Risk 46 · Elevated
Price$4.72
Model IV—
P/IV—
Limited data — see page
NKTR
NEKTAR THERAPEUTICS
Valuation N/A
Healthcare Risk 31 · Moderate
Price$68.50
Model IV—
P/IV—
Market implies +95.7%/yr vs model +2.0% · above model
NKTX
Nkarta, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$2.92
Model IV—
P/IV—
Limited data — see page
NKX
NUVEEN CALIFORNIA AMT-FREE QUALITY MUNICIPAL INCOME FUND
Valuation N/A
Unknown
Price$11.35
Model IV—
P/IV—
Limited data — see page
NMAI
Nuveen Multi-Asset Income Fund
Valuation N/A
Unknown
Price$14.11
Model IV—
P/IV—
Limited data — see page
NMAX
Newsmax Inc.
Valuation N/A
Communication Services Risk 46 · Elevated
Price$10.63
Model IV—
P/IV—
Market implies +33.0%/yr vs model +10.7% · above model
NMCO
Nuveen Municipal Credit Opportunities Fund
Valuation N/A
Unknown
Price$9.51
Model IV—
P/IV—
Limited data — see page
NMG
Nouveau Monde Graphite Inc.
Valuation N/A
Basic Materials Risk 55 · Elevated
Price$1.35
Model IV—
P/IV—
Limited data — see page
NMI
NUVEEN MUNICIPAL INCOME FUND INC
Valuation N/A
Unknown
Price$10.39
Model IV—
P/IV—
Limited data — see page
NML
Neuberger Energy Infrastructure & Income Fund Inc.
Valuation N/A
Unknown
Price$10.64
Model IV—
P/IV—
Limited data — see page
NMP
NMP Acquisition Corp.
Valuation N/A
Financial Services
Price$10.36
Model IV—
P/IV—
Limited data — see page